vs
Niagen Bioscience, Inc.（NAGE）与SNDL Inc.（SNDL）财务数据对比。点击上方公司名可切换其他公司
SNDL Inc.的季度营收约是Niagen Bioscience, Inc.的2.3倍（$77.5M vs $33.8M）
Niagen Bioscience（原名为ChromaDex）是一家成立于1999年，总部位于加利福尼亚州洛杉矶的生物科技公司。公司业务涵盖标准品、膳食补充剂以及原料技术开发多个领域，目前在纳斯达克挂牌上市。
SNDL Inc.是总部位于加拿大的消费品企业，核心业务覆盖大麻产业，提供娱乐及医用大麻产品，同时运营精酿啤酒、葡萄酒、烈酒等酒饮产品线，业务涵盖种植、研发、分销、零售环节，主要服务北美市场的批发及零售客户。
NAGE vs SNDL — 直观对比
营收规模更大
SNDL
是对方的2.3倍
$33.8M
损益表 — Q4 2025 vs Q1 2025
| 指标 | | |
|---|---|---|
| 营收 | $33.8M | $77.5M |
| 净利润 | $4.1M | — |
| 毛利率 | 64.1% | 25.3% |
| 营业利润率 | 12.1% | 6.7% |
| 净利率 | 12.2% | — |
| 营收同比 | 16.2% | — |
| 净利润同比 | -42.4% | — |
| 每股收益（稀释后） | $0.05 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NAGESNDL
| Q4 25 | $33.8M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $31.1M | — | ||
| Q1 25 | $30.5M | $77.5M | ||
| Q4 24 | $29.1M | — | ||
| Q3 24 | $25.6M | — | ||
| Q2 24 | $22.7M | — | ||
| Q1 24 | $22.2M | $116.1M |
净利润NAGESNDL
| Q4 25 | $4.1M | — | ||
| Q3 25 | $4.6M | — | ||
| Q2 25 | $3.6M | — | ||
| Q1 25 | $5.1M | — | ||
| Q4 24 | $7.2M | — | ||
| Q3 24 | $1.9M | — | ||
| Q2 24 | $-15.0K | — | ||
| Q1 24 | $-492.0K | — |
毛利率NAGESNDL
| Q4 25 | 64.1% | — | ||
| Q3 25 | 64.5% | — | ||
| Q2 25 | 65.0% | — | ||
| Q1 25 | 63.4% | 25.3% | ||
| Q4 24 | 62.5% | — | ||
| Q3 24 | 63.5% | — | ||
| Q2 24 | 60.2% | — | ||
| Q1 24 | 60.7% | 24.8% |
营业利润率NAGESNDL
| Q4 25 | 12.1% | — | ||
| Q3 25 | 12.5% | — | ||
| Q2 25 | 10.2% | — | ||
| Q1 25 | 15.7% | 6.7% | ||
| Q4 24 | 24.4% | — | ||
| Q3 24 | 6.3% | — | ||
| Q2 24 | -1.1% | — | ||
| Q1 24 | -3.3% | 1.9% |
净利率NAGESNDL
| Q4 25 | 12.2% | — | ||
| Q3 25 | 13.5% | — | ||
| Q2 25 | 11.6% | — | ||
| Q1 25 | 16.6% | — | ||
| Q4 24 | 24.6% | — | ||
| Q3 24 | 7.3% | — | ||
| Q2 24 | -0.1% | — | ||
| Q1 24 | -2.2% | — |
每股收益（稀释后）NAGESNDL
| Q4 25 | $0.05 | — | ||
| Q3 25 | $0.05 | — | ||
| Q2 25 | $0.04 | — | ||
| Q1 25 | $0.06 | — | ||
| Q4 24 | $0.10 | — | ||
| Q3 24 | $0.02 | — | ||
| Q2 24 | $0.00 | — | ||
| Q1 24 | $-0.01 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $76.5M | — |
| 总资产 | $106.4M | — |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NAGESNDL
| Q4 25 | — | — | ||
| Q3 25 | $64.1M | — | ||
| Q2 25 | $60.3M | — | ||
| Q1 25 | $55.5M | — | ||
| Q4 24 | $44.5M | — | ||
| Q3 24 | $32.2M | — | ||
| Q2 24 | $27.7M | — | ||
| Q1 24 | $27.4M | — |
股东权益NAGESNDL
| Q4 25 | $76.5M | — | ||
| Q3 25 | $70.7M | — | ||
| Q2 25 | $64.2M | — | ||
| Q1 25 | $55.3M | — | ||
| Q4 24 | $46.1M | — | ||
| Q3 24 | $34.4M | — | ||
| Q2 24 | $30.7M | — | ||
| Q1 24 | $29.0M | — |
总资产NAGESNDL
| Q4 25 | $106.4M | — | ||
| Q3 25 | $98.1M | — | ||
| Q2 25 | $91.5M | — | ||
| Q1 25 | $81.3M | — | ||
| Q4 24 | $68.3M | — | ||
| Q3 24 | $56.5M | — | ||
| Q2 24 | $54.0M | — | ||
| Q1 24 | $54.1M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $679.0K | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 0.16× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流NAGESNDL
| Q4 25 | $679.0K | — | ||
| Q3 25 | $3.7M | — | ||
| Q2 25 | $1.3M | — | ||
| Q1 25 | $7.9M | — | ||
| Q4 24 | $8.6M | — | ||
| Q3 24 | $3.5M | — | ||
| Q2 24 | $-264.0K | — | ||
| Q1 24 | $295.0K | — |
现金转化率NAGESNDL
| Q4 25 | 0.16× | — | ||
| Q3 25 | 0.81× | — | ||
| Q2 25 | 0.35× | — | ||
| Q1 25 | 1.56× | — | ||
| Q4 24 | 1.20× | — | ||
| Q3 24 | 1.86× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NAGE
| TRUNIAGEN Consumer Product | $27.5M | 81% |
| Ingredients Segment | $5.7M | 17% |
| Other | $694.0K | 2% |
SNDL
暂无分部数据
